24 May 2024: QScint announces installation of flagship iQID NSight Mega particle imager at Washington University in St. Louis
St. Louis, MO and Tucson, AZ - May 24 2024 - QScint Imaging Solutions LLC (QScint), a world-leader in the production of real-time, quantitative alpha- and beta-particle imagers for radiopharmaceutical therapy research and digital autoradiography in both academia and industry today announced the installation of its iQID NSight Mega particle imager at Washington University in St. Louis. The installation expands QScint’s world-wide install base to another academic site, putting its patented technology in the hands of talented researchers.
“We’re pleased to make our latest install in one of the Midwest’s major research and academic hubs.” said Dr. Brian Miller, President of QScint. “This install will advance the state-of-the-art in pre-clinical micro-scale dosimetry with alpha particle radiopharmaceuticals. We’re excited to see what new breakthroughs Dr. Bastiaannet produces with his iQID.”
